Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
GlaxoSmithKline will purchase Novartis' 36.5 percent stake in their consumer healthcare joint venture for $13 billion, according to Reuters.
Operating room (OR) surgeons and nurses face extraordinary challenges, to say the least. The OR is among the most expensive hospital areas to run1, as well as one of the most stressful.
John Roy, Vice President and General Manager, Cardinal Health Inventory Management Solutions
The FDA's Center for Devices and Radiological Health plans to expand its digital health pre-certification pilot program by the end of 2018, the center's associate director for digital health Bakul Patel said March 22, according to Regulatory Focus.
HHS Secretary Alex Azar selected CVS Caremark Vice President Daniel Best to lead the agency's push to curb drug prices, a source familiar with the hire told Politico.
The American Red Cross was forced to cancel more than 350 blood drives in March as a string of winter storms pummeled the U.S. — greatly depleting blood supply across the nation.
Monteris Medical recalled its NeuroBlate System and coinciding Laser Delivery Probes due to numerous instances of device malfunctions, according to a March 22 recall alert from the FDA.
GlaxoSmithKline reportedly pulled its bid to purchase Pfizer's consumer healthcare business March 23, according to Reuters.
President Donald Trump's administration implemented a payment policy change that could increase the price of biosimilars, according to The Wall Street Journal.
Here are the four latest drugs or medical devices approved by the FDA since March 9.
Americans identified pharmaceutical companies as one of the most influential parties in Washington, D.C., in a poll conducted by Kaiser Family Foundation.